BDNF and Anxiety: For example, the TrkB agonists have dose dependent effects on plasma BDNF concentrations and it is noted that higher plasma BDNF concentrations during the clinical trial were correlated with greater improvement in depressive and anxiety symptoms, suggesting that BDNF may serve as a potential biomarker to customize treatment strategies [178].